Stock listing

Inhibikase Therapeutics, Inc.

Selected listing: IKT · BOATS · USD · US

Inhibikase Therapeutics, Inc. (BOATS:IKT), Health Technology. Latest release Oct 2, 2026: Inhibikase Therapeutics Announces Inducement Grants Under Nasdaq…

IKT:BOATSUSDUSUpdated October 2, 2026
Inhibikase Therapeutics, Inc. logo
Ticker
BOATS:IKT
Asset type
Stock
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
BOATS
Currency
USD

About Inhibikase Therapeutics, Inc.

Inhibikase Therapeutics, Inc. is a public company traded under the ticker IKT in the American market. Inhibikase is focused on developing innovative therapies for neurodegenerative diseases.

Latest news from Inhibikase Therapeutics, Inc.

All Inhibikase Therapeutics, Inc. news →

Events

Replays

  • Inhibikase Therapeutics, Inc. (IKT) Q2 2024 Earnings Call

    Thu, Aug 15, 2024 · 08:00 AM ET

    Watch
  • Inhibikase Therapeutics, Inc. (IKT) Q1 2024 Earnings Call

    Thu, May 16, 2024 · 08:00 AM ET

    Watch
  • Inhibikase Therapeutics, Inc. (IKT) Q4 2023 Earnings Call

    Thu, Mar 28, 2024 · 08:00 AM ET

    Watch

Research Inhibikase Therapeutics, Inc.

Alternate listings